baber/WOPTO huggingface dataset:
Patent EP-3788523-A1 (EP)
Inventor: LI SHUBO
IPC: G06F21/45
Filed: 2019-08-30
Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for blockchain-based cross-entity authentication are provided. One of the methods includes: obtaining, from a blockchain, a blockchain transaction comprising an authentication request by a first entity for authenticating a user, wherein the authentication request comprises a decentralized identifier (DID) of the user; in response to determining that the first entity is permitted to access authentication information of the user endorsed by a second entity, obtaining an authentication result of the user by the second entity in response to the obtained blockchain transaction, wherein the authentication result is associated with the DID; generating a different blockchain transaction comprising the authentication result; and transmitting the different blockchain transaction to a blockchain node for adding to the blockchain.
Patent EP-3904481-A1 (EP)
Inventor: CHINO KEISUKE
IPC: C08K3/00
Filed: 2019-12-24
Abstract: [Problem to be Solved] 
     To provide a silane compound for obtaining a cross-linked product which hardly generates poor dispersion or adhesion between an organic polymer material and an inorganic material and exhibits excellent viscoelastic properties or adhesive properties, or a composition comprising the silane compound. 
     [Means for solving the problem] 
     A silane compound represented by formula (1):
     
wherein R 1 , R 2 , and R 3  each independently represents a hydrocarbon group optionally containing an oxygen atom or a nitrogen atom, or a hydrogen atom; 
L represents a hydrocarbon group optionally containing at least one heteroatom selected from the group consisting of nitrogen, oxygen, and sulfur; 
a is an integer of 0 or 1; 
b is an integer of 0 or 1; 
c is each independently an integer of 0 or 1; 
d is each independently an integer of 0 or 1; 
e is an integer from 0 to 5; 
R 4 , R 5 , R 6 , and R 7  represent a hydrogen atom, a methyl group, or an alkyl group having 2 to 10 carbons, or one of R 4  or R 5  and R 6  or R 7  may form a cross-linked structure represented by -(CH 2 ) f -, and f is an integer from 1 to 5; 
R 8 , R 9 , R 10  and R 11  represent a hydrogen atom, a methyl group or an alkyl group having 2 to 10 carbons, or one of R 8  or R 9  and R 10  or R 11  may form a cross-linked structure represented by -(CH 2 ) g -, g is an integer from 1 to 5, R 16  is a hydrogen atom, a methyl group or an alkyl group having 2 to 8 carbons and R 17  is a hydrogen atom, a methyl group or an alkyl group having 2 to 10 carbons, where R 12  and R 13  bond to each other to form a double bond and R 14 , R 15 , and R 18  are a hydrogen atom, a methyl group or an alkyl group having 2 to 10 carbons, or R 14  and R 15  bond to each other to form a double bond and R 12 , R 13 , and R 18  are a hydrogen atom, a methyl group or an alkyl group having 2 to 10 carbons; or 
R 16  and R 17  may bond to each other to form a 4 to 9 membered alicyclic hydrocarbon, where R 14  and R 15  bond to each other to form a double bond and R 12 , R 13 , and R 18  are a hydrogen atom, a methyl group or an alkyl group having 2 to 10 carbons.
Patent EP-3905049-A1 (EP)
Inventor: YANG YI
IPC: G06F11/34
Filed: 2019-12-17
Abstract: One or more embodiments of this specification provide a method, an apparatus, a device, and a storage medium for displaying application performance management information. The method includes: separately obtaining first and second performance status information of services provided by a first application and a second application; determining first and second display specifications of respective graphics corresponding to the first and second performance status information, to enable a ratio of the first display specification to the second display specification to be not greater than a preset value; and displaying the respective graphics corresponding to the first and second performance status information according to the determined first and second display specifications.
Patent EP-3873145-A1 (EP)
Inventor: LIU JIANHUA
IPC: H04W60/00
Filed: 2019-01-16
Abstract: Embodiments of the present application provide a service authorization method, a terminal device and a network device. Aiming at NCIS, the network device can authorize the terminal device, so that the terminal device can carry out the NCIS smoothly. The service authorization method includes: receiving, by a terminal device, first information, where the first information includes first indication information used to indicate whether a first service is allowed, the first service supports transmission on a side direct interface and a wireless interface, terminal devices in a session for the first service belong to a same group, and the terminal devices in the same group come from at least one public land mobile network PLMN
Patent EP-3949912-A1 (EP)
Title: Thumb-based hand motion control system for myoelectric hand and control method thereof
Inventor: PARK SE HOON
IPC: A61F2/50
Filed: 2019-06-12
Abstract: The present invention relates to a hand motion control system and a control method thereof, and more specifically, to a hand motion control system for a myoelectric hand, and to a control method thereof. The system enables not only grasping motions for grasping an object, but also the expression of hand gestures expressing emotions or intent, by means of a limited myoelectric signal transmitted via two myoelectric sensors provided on the myoelectric hand. Furthermore, the system enables a wide variety of hand postures and grasp types that are determined by the position of a thumb, which can be changed by a user, thus easily expanding the range of applications of the myoelectric hand.
Patent EP-3927456-A1 (EP)
Inventor: AGEE KENNETH L
IPC: B01J8/06
Filed: 2019-10-03
Abstract: A stacked zone vertical tubular reactor for conducting an exothermic reaction. The reactor may comprise two or more stacked catalyst zones in each reactor tube. Each reactor tube may contain internal feed and discharge tubes, transition zones comprising a catalyst support plate and a zone separator plate, and a heat transfer element located in each catalyst zone.
Patent EP-3923312-A1 (EP)
Inventor: KAWASE JUNYA
IPC: H01J35/16
Filed: 2019-04-15
Abstract: X-ray generation apparatus includes an X-ray generation tube including a cathode having an electron emitting portion, and an anode having a target, a voltage supply supplying voltage to the X-ray generation tube via a conductive line, a storage container having a first portion forming a first space storing the voltage supply, a second portion forming a second space storing the X-ray generation tube, and a connecting portion connecting the first portion and the second portion, and an insulating liquid filling internal space of the storage container. The connecting portion includes a convex portion pointed toward the internal space. The cathode is arranged between the convex portion and the anode, and an insulating member is arranged to surround portion of the conductive line and block shortest path between the conductive line and the convex portion.
Patent EP-3977867-A1 (EP)
Inventor: NAKATA AKI
IPC: A23L2/52
Filed: 2019-11-01
Abstract: An object of the present invention is to provide a packaged beverage that comprises high concentrations of 1-deoxynojirimycin but has a pleasant aftertaste. 
     Magnesium and/or calcium is added at a concentration of from 0.05 to 15 mg/100 mL to a packaged beverage comprising 1-deoxynojirimycin at a concentration of from 0.1 to 0.75 mg per 100 mL of the beverage and having a soluble solids concentration of not more than 2.0.
Patent EP-3886528-A1 (EP)
Title: Cell state management method and apparatus, terminal device, and network device
Inventor: WANG SHUKUN
IPC: H04W76/27
Filed: 2019-11-04
Abstract: The embodiments of the present application provide a cell state management method and apparatus, a terminal device, and a network device. The method includes: receiving, by a terminal device, first configuration information sent by a network device, where the first configuration information is used to indicate whether a state of a first cell is a first state or a second state, the first state represents an active state with a dormancy behavior, and the second state represents an active state with a non-dormancy behavior.
Patent EP-4083557-A1 (EP)
Title: Heat exchanger unit and refrigeration cycle device
Inventor: MAEDA TSUYOSHI
IPC: F28D1/053
Filed: 2019-12-25
Abstract: A heat-exchanger unit and a refrigeration cycle apparatus are to be provided that are each configured to reduce attenuation of vortex flows of air that occurs when the air passes through spaces between heat transfer parts of a heat exchanger. The heat-exchanger unit and the refrigeration cycle apparatus each include the heat exchanger, a fan configured to supply air to the heat exchanger, and a vortex generator located upstream of the heat exchanger in a direction in which the air flows and configured to generate a vortex flow of the air. The heat exchanger is provided with a plurality of heat transfer parts that are arranged at intervals in a first direction. The plurality of heat transfer parts are each provided with a refrigerant passage portion through which refrigerant flows inside the refrigerant passage portion in a second direction that intersects the first direction, and a fin portion that extends from the refrigerant passage portion toward the vortex generator. Where a virtual line passes through a center of a width of the refrigerant passage portion in the first direction and extends in a third direction that is orthogonal to the first direction and the second direction, the fin portion overlaps with the virtual line in position.
Patent EP-3692944-A1 (EP)
Title: Surgical drill guide for edentulous patients
Inventor: ROSHKOVAN IGOR
IPC: A61C1/08
Filed: 2020-03-16
Abstract: The embodiment provides a set of surgical drill guides for upper (10) and lower jaw and aimed at locating ideal position for dental implants in edentulous patients and comprising a surgical stent material from metal or other rigid material that is aligned to provide support and stability of fully edentulous upper and lower jaw to navigate orientation surgical drills in area of operation (65). The present embodiment comprises a U-shape a metal plate provided form or shaped resembling a toothless upper or lower jaw and containing a top surface (11) of the surgical stent that contacting the soft tissue of maxilla or mandibula and the bottom surface of the stent has the some shape as a top one.
Patent EP-4006139-A1 (EP)
Inventor: KOGEJ TINA
IPC: C12N1/00
Filed: 2020-11-26
Abstract: The present invention generally relates to the biotechnology engineering, and specifically to a genetically engineered bacterium capable of producing cytokinins with isoprenoid side chains (isoprenoid cytokinins), and the preparation and application thereof.
Patent EP-3702151-A1 (EP)
Inventor: DI TRAPANI PAOLO
IPC: F21V9/02
Filed: 2016-11-15
Abstract: A chromatic stratified panel structure (100) for generating a sun-sky-imitating effect in lighting systems (1) comprises two cover panels (102, 104) at least one of which being a transparent panel; an adhesive transparent polymeric layer (106) sandwiched between the two inner faces of the two cover panels; and at least one nanoparticle-based Rayleigh-like diffusing coating (108) applied to an inner face of at least one of the two cover panels (102, 104) and/or to a face of the adhesive transparent polymeric layer (106) and forming an interlayer between one of the cover panels (102, 104) and the adhesive transparent polymeric layer (106).
Patent EP-3699592-A1 (EP)
Title: Non-replicative transduction particles and transduction particle-based reporter systems
Inventor: REY DIEGO ARIEL
IPC: C12P19/34
Filed: 2014-03-13
Abstract: Methods and systems are provided for packaging reporter nucleic acid molecules into non-replicative transduction particles for use as reporter molecules. The non-replicative transduction particles can be constructed from viruses and use viral transduction and replication systems. The reporter nucleic acid molecules include a reporter gene, such as a reporter molecule or selectable marker, for detecting target genes or cells. Methods and systems are provided for detection of cells and target nucleic acid molecules using the non-replicative transduction particles as reporter molecules.
Patent EP-3719137-A1 (EP)
Inventor: AMBROSINI GRAZIA
IPC: G01N33/53
Filed: 2014-09-05
Abstract: The present invention relates to methods and compositions for determining the likelihood that a subject suffering from a cancer will benefit from treatment with a MEK inhibitor. It also relates to methods of treatment based on such determination. The invention is based, at least in part, on the discoveries that DDX43 mRNA and protein are expressed at high levels in biopsies from "non-responder" UM patients and that selumetinib-resistant cell lines showed high DDX43 expression which correlated with increased expression and activity of RAS. It was found that KRAS and HRAS but not NRAS, mediated expression of pERK and pAKT, bypassing oncogenic GNAQ. The invention is further based on the discovery that selumetinib-resistant cells became sensitive to AKT inhibition, suggesting alternative strategies for the treatment of cancer patients with acquired resistance to MEK inhibitors.
Patent EP-3711503-A1 (EP)
Title: Réceptacle repliable pour du tabac en vrac et carnet repliable qui l'intègre
Inventor: PARTOUCHE OLIVIER
IPC: A24F23/00
Filed: 2020-02-17
Abstract: La présente invention se rapporte notamment à un réceptacle (1) repliable pour du tabac en vrac, qui est délimité par deux parois longitudinales (10, 11) qui présentent un côté longitudinal commun (101), et par deux parois transversales (12, 13) opposées en forme de soufflet, caractérisé par le fait que lesdites parois transversales (12, 13) en forme de soufflet sont constituées de cinq plis successifs (P1, P2, P3, P4, P5), et que les deux éléments voisins (122, 123) de paroi transversale qui constituent au moins un (P4) desdits plis sont configurés pour occuper soit une première position dans laquelle ils forment un angle rentrant, soit une deuxième position dans laquelle ils forment un angle sortant et constituent ainsi un bec verseur.
Patent EP-3687194-A1 (EP)
Inventor: STARSINIC MICHAEL F
IPC: H04W4/70
Filed: 2014-07-08
Abstract: Capillary network devices (i.e., IMSI-less devices) may connect to an EPC through a home WLAN. A WILAN can be configured by the homeowner to accept responsibility for the traffic or a WLAN can indicate to a network that it will allow the traffic if the traffic is sponsored by an application server or if it is compensated for the traffic by the network operator. Where an IM-SI-less devise has a business relationship with a network operator, a WLAN can allow the device to authenticate with the network and obtain a device identifier from the network. Where an IMSI-less device has a business relationship with a SCS that has a business relationship with the network operator, the WLAN can allow the devise to authenticate with the network.
Patent EP-3878471-A1 (EP)
Inventor: MEINEL LORENZ
IPC: A61P29/00
Filed: 2020-03-13
Abstract: The present invention discloses a therapeutic system for the topic, transdermal and transcutaneous application of carbon monoxide (CO), comprising: (i) an adhesive layer, (ii) a gas-permeable and liquid- and solid-impermeable membrane, (iii) a reaction chamber comprising a CO releasing molecule A, and (iv) a gas-impermeable backing layer, wherein the transdermal therapeutic system is configured that the CO releasing molecule A can be brought into contact with a CO release triggering compound B in the reaction chamber (iii). The therapeutic system can be used for the treatment of wounds, inflammatory diseases of the skin, and inflammatory diseases of subcutaneous skin tissue, joints and tendons.
Patent EP-3757785-A1 (EP)
Inventor: BALLE SUSANNE M
IPC: G06F9/54
Filed: 2020-03-27
Abstract: Technologies for facilitating remote memory requests in accelerator devices are disclosed. The accelerator device includes circuitry to receive, from a kernel of the present accelerator device, a request through an application programming interface exposed to a high level software language in which the kernel of the present accelerator device is implemented, to establish a logical communication path between the kernel of the present accelerator device and a target accelerator device kernel, based on one or more physical communication paths. The communication protocol supported by the accelerator device may allow kernels operating on the accelerator device to send memory requests for memory locations at remote devices, with the communication protocol performing all of the operations necessary to carry out the memory request.
Patent EP-3694286-A1 (EP)
Inventor: BARON STéPHANE
IPC: H04W84/12
Filed: 2016-07-08
Abstract: In 802.1 1ax networks with access points, a trigger frame offers scheduled and random resource units to nodes for data uplink communication to the access points. To make more effective the usage of the network, it is described a communication apparatus comprising: receiving means for receiving a trigger frame including information of a plurality of resource units splitting one or more communication channels in a frequency domain and, for each of the plurality of resource units, information indicating an access category which categorizes data; and sending means for sending data using at least one of the plurality of resource units in response to the received trigger frame.
Patent EP-3750530-A1 (EP)
Inventor: REUVENI HADAS
IPC: A61K31/505
Filed: 2016-02-04
Abstract: The present invention relates to the treatment of cancer using combination therapy comprising a dual modulator of Insulin Receptor Substrate (IRS) and signal transducer and activator of transcription 3 (Stat3), in combination with (i) a modulator of a protein kinase (PK) selected from an Epidermal Growth Factor inhibitor (EGFR inhibitor) and EGFR antibody; (ii) an inhibitor of mammalian target of rapamycin (m TOR); (iii) a mitogen-activated protein kinase (MEK) inhibitor; (iv) a mutated B-Raf inhibitor; (v) a chemotherapeutic agent like Gemcitabine, 5-FU, Irinotecan and Oxaliplatin; and (vi) certain combinations thereof. The combination can be used to treat a tumor that has developed resistance to an EGFR inhibitor, EGFR antibody, m TOR inhibitor, MEK inhibitor, mutated B-Raf inhibitor, chemotherapeutic agents, and certain combinations thereof, or to prevent acquired resistance of a tumor to any of said inhibitors or agents, or to prevent tumor recurrence following cease of treatment with any of said inhibitors or agents or a combination thereof. The combination provides a therapeutic effect which is at least additive, and is preferably synergistic. The present invention further relates to the treatment of cancer using combination therapy comprising a dual modulator of IRS and Stat3, in combination with an immunotherapy agent. The combination can be used to sensitize a tumor to immunotherapy.
Patent EP-3834667-A1 (EP)
Title: Adjustable bed
Inventor: WANG WEI
IPC: A47C31/00
Filed: 2020-05-11
Abstract: An adjustable bed system includes a pair of side rails transversely spaced, longitudinally aligned and arranged parallel to each other; and a pair of lifting assemblies attached respectively to the pair of side rails for operably adjusting positions of at least one part of a bed. Each lifting assembly comprises a back lifting arm and a leg lifting mechanism; a bracket; and a back lifting actuator and a leg lifting actuator received in the bracket. Each actuator includes an activation member and a motor member engaged with the activation member for driving the activation member. The activation member of the back lifting actuator is engaged with the back lifting arm for operably adjusting the back lifting arm at desired back positions. The activation member of the leg lifting actuator is engaged to the leg lifting mechanism for operably adjusting the leg lifting mechanism at desired leg positions.
Patent EP-3721887-A1 (EP)
Inventor: WON YOU-YEON
IPC: A61K33/24
Filed: 2016-01-08
Abstract: The invention relates generally to a formulation in which metal tungstate or metal molybdate particles are encapsulated within biocompatible, diseased cell-targeting polymeric coatings. Such formulations render metal tungstate or metal molybdate particles suitable for in vivo biomedical imaging and therapeutic applications.
Patent EP-3744538-A1 (EP)
Title: Tire
Inventor: MISHIMA MARI
IPC: B60C11/03
Filed: 2020-05-27
Abstract: In a tire having composite grooves provided on a shoulder land portion, dry performance and wet performance are improved. The tire includes a tread portion 2. The tread portion 2 includes a first shoulder land portion 13. The first shoulder land portion 13 has shoulder lateral grooves 15 and shoulder composite grooves 20. The shoulder lateral grooves 15 and the shoulder composite grooves 20 are each curved so as to be convex in a tire circumferential direction. Each shoulder composite groove 20 includes, in a cross section thereof, a sipe element 21 having a width not greater than 1.5 mm and extending from a tread surface of the first shoulder land portion 13 in a tire radial direction, and a groove element 22 connected to an inner side in the tire radial direction of the sipe element 21 and having a width greater than 1.5 mm.
Patent EP-3725309-A1 (EP)
Inventor: KELLEY MARK R
IPC: A61K33/243
Filed: 2008-09-22
Abstract: Disclosed are novel methods for the therapeutic treatment of cancer and angiogenesis. The enzyme Apel/Ref-1, via its redox function, enhances the DNA binding activity of transcription factors that are associated with the progression of cancer. The present invention describes the use of agents to selectively inhibit the redox function of Apel/Ref-1 and thereby reduce tumor cell growth, survival, migration and metastasis. In addition, Apel/Ref-1 inhibitory activity is shown to augment the therapeutic effects of other therapeutics and protect normal cells against toxicity. Further, Apel/Ref-1 inhibition is shown to decrease angiogenesis, for use in the treatment of cancer as well other pathologic conditions of which altered angiogenesis is a component.
Patent EP-3808343-A1 (EP)
Title: Novel pharmaceutical composition
Inventor: DEMARINI DOUGLAS J
IPC: A61K9/20
Filed: 2011-12-20
Abstract: Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Patent EP-3930024-A1 (EP)
Inventor: NÜLLEN MAX PETER
IPC: H01L51/54
Filed: 2020-06-22
Abstract: The present invention relates to an organic electronic device comprising a semiconductor layer which comprises a mixture of isomeric compounds.
Patent EP-3741785-A1 (EP)
Inventor: DOMINGUES DOS SANTOS FABRICE
IPC: C08J5/18
Filed: 2013-12-09
Abstract: L'invention concerne un polymère comprenant des unités structurales de fluorure de vinylidène, de trifluoroéthylène et de chlorotrifluoroéthylène, le rapport molaire entre le fluorure de vinylidène et le trifluoroéthylène dans le polymère étant de 55:45 à 65:35, et la proportion molaire des unités structurales de chlorotrifluoroéthylène dans le polymère étant de 1,5 à 5,5 %.L'invention concerne également divers articles comprenant ce polymère, tels que des films, des fibres, des plaques extrudées et des articles moulés.